Lisa N. Gillespie, Ph D

Affiliations: 
Bionics Institute 
Area:
Auditory neuroscience
Website:
http://www.bionicsinstitute.org/our-staff/Pages/lisa-pettingill.aspx
Google:
"Lisa Gillespie"
Mean distance: 17.4 (cluster 39)
 
Cross-listing: CSD Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gillespie LN, Zanin MP, Shepherd RK. (2015) Cell-based neurotrophin treatment supports long-term auditory neuron survival in the deaf guinea pig. Journal of Controlled Release : Official Journal of the Controlled Release Society. 198: 26-34
Gillespie LN, Richardson RT, Nayagam BA, et al. (2014) Treating hearing disorders with cell and gene therapy. Journal of Neural Engineering. 11: 065001
Irving S, Gillespie L, Richardson R, et al. (2014) Electroacoustic stimulation: now and into the future. Biomed Research International. 2014: 350504
Zanin MP, Hellström M, Shepherd RK, et al. (2014) Development of a cell-based treatment for long-term neurotrophin expression and spiral ganglion neuron survival. Neuroscience. 277: 690-9
Wise AK, Gillespie LN. (2012) Drug delivery to the inner ear Journal of Neural Engineering. 9
Gillespie LN, Shepherd RK. (2005) Clinical application of neurotrophic factors: the potential for primary auditory neuron protection. The European Journal of Neuroscience. 22: 2123-33
Gillespie LN, Marzella PL, Clark GM, et al. (2005) Netrin-1 as a guidance molecule in the postnatal rat cochlea. Hearing Research. 199: 117-23
Gillespie LN, Clark GM, Marzella PL. (2004) Delayed neurotrophin treatment supports auditory neuron survival in deaf guinea pigs. Neuroreport. 15: 1121-5
Gillespie LN. (2003) Regulation of axonal growth and guidance by the neurotrophin family of neurotrophic factors Clinical and Experimental Pharmacology and Physiology. 30: 724-733
Gillespie LN, Clark GM, Bartlett PF, et al. (2003) BDNF-induced survival of auditory neurons in vivo: Cessation of treatment leads to accelerated loss of survival effects. Journal of Neuroscience Research. 71: 785-90
See more...